Average Co-Inventor Count = 4.76
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurosearch A/s (72 from 206 patents)
2. Abbott Laboratories Corporation (1 from 4,179 patents)
3. Aniona Aps (5 patents)
72 patents:
1. 8410271 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
2. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
3. 8343960 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
4. 8263617 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
5. 8236793 - Diazabicyclic aryl derivatives as cholinergic receptor modulators
6. 8173658 - Diazabicycylic aryl derivatives and their medical use
7. 8158619 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
8. 8148365 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
9. 8110588 - 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
10. 8110586 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11. 8101598 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12. 8022081 - Naphthyl substituted azabicyclo derivatives and their use as monomine neurotransmitter re-uptake inhibitors
13. 8017631 - Oxadiazole derivatives and their medical use
14. 7989470 - 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
15. 7973082 - Substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors